X-RX, Inc.
Records under this name other than patents X-RX, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to X-RX, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,951,056 | Substituted Nicotinamide Inhibitors of BTK and Their Preparation and Use in the Treatment of Cancer, Inflammation and Autoimmune Disease Formerly held In force · High confidence | In force | High confidence | |
| US 9,394,256 | Benzhydrol-Pyrazole Derivatives Having Kinase Inhibitory Activity and Uses Thereof Formerly held Lapsed on the fee record Ended Jul 19, 2024 · High confidence | Lapsed on the fee record | Ended Jul 19, 2024 | High confidence |
| US 9,394,296 | Tryptoline Derivatives Having Kinase Inhibitory Activity and Uses Thereof Formerly held Lapsed on the fee record Ended Jul 19, 2024 · High confidence | Lapsed on the fee record | Ended Jul 19, 2024 | High confidence |
| US 10,233,182 | Substituted Spirocyclic Inhibitors of Autotaxin Lapsed on the fee record Ended Mar 19, 2023 · High confidence | Lapsed on the fee record | Ended Mar 19, 2023 | High confidence |
| US 10,011,601 | Substituted Spirocyclic Inhibitors of Autotaxin Lapsed on the fee record Ended Jul 3, 2022 · High confidence | Lapsed on the fee record | Ended Jul 3, 2022 | High confidence |